selected publications
- Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers. 2024 GET IT
- Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer. NPJ breast cancer. 2024 Review GET IT
- Validation and Responsiveness of the English version of the Chemotherapy-Induced Alopecia Distress Scale (CADS) in Breast Cancer Patients. 2023 GET IT
-
A prospective longitudinal analysis of the predictors of amenorrhea after breast cancer chemotherapy: Impact of BRCA pathogenic variants.
Cancer medicine.
2023
Academic Article
GET IT
Times cited: 5 -
Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.
Breast cancer research and treatment.
2023
Academic Article
GET IT
Times cited: 5 -
RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study.
Journal of the National Cancer Institute.
2023
Comment
GET IT
Times cited: 2 -
Pregnancy-associated breast cancer: does timing of presentation affect outcome?.
Breast cancer research and treatment.
2023
Academic Article
GET IT
Times cited: 2 -
Shared decision making for patients with breast and gynecologic malignancies undergoing chemotherapy associated with persistent alopecia.
Gynecologic oncology reports.
2022
Academic Article
GET IT
Times cited: 1 -
Fertility Preservation in Young Women with Breast Cancer: Impact on Treatment and Outcomes.
Annals of surgical oncology.
2022
Academic Article
GET IT
Times cited: 1 - Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer. Breast cancer research and treatment. 2022 Academic Article GET IT
-
Timing of Presentation and Outcomes of Women with Stage IV Pregnancy-Associated Breast Cancer (PABC).
Annals of surgical oncology.
2021
Academic Article
GET IT
Times cited: 3 -
Correspondence Between Clinician Ratings of Vulvovaginal Health and Patient-Reported Sexual Function After Cancer.
The journal of sexual medicine.
2021
Academic Article
GET IT
Times cited: 4 - Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2020 Academic Article GET IT
-
A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia.
Breast cancer research and treatment.
2020
Academic Article
GET IT
Times cited: 2 -
Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer.
Breast cancer research and treatment.
2020
Academic Article
GET IT
Times cited: 19 -
Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?.
Annals of surgical oncology.
2020
Academic Article
GET IT
Times cited: 9 -
A single-arm clinical trial investigating the effectiveness of a non-hormonal, hyaluronic acid-based vaginal moisturizer in endometrial cancer survivors.
Gynecologic oncology.
2020
Academic Article
GET IT
Times cited: 19 -
A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
2020
Academic Article
GET IT
Times cited: 25 -
Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency.
Fertility and sterility.
2020
Academic Article
GET IT
Times cited: 48 -
Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical Trial.
JAMA network open.
2019
Academic Article
GET IT
Times cited: 8 -
A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.
Investigational new drugs.
2019
Academic Article
GET IT
Times cited: 9 -
Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia.
JAMA dermatology.
2019
Academic Article
GET IT
Times cited: 56 -
Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies.
Breast cancer research and treatment.
2018
Information Resource
GET IT
Times cited: 33 -
Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer.
JAMA dermatology.
2018
Academic Article
GET IT
Times cited: 68 -
Hair disorders in cancer survivors.
Journal of the American Academy of Dermatology.
2018
Information Resource
GET IT
Times cited: 58 -
Hair disorders in patients with cancer.
Journal of the American Academy of Dermatology.
2018
Review
GET IT
Times cited: 67 -
Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2017
Guideline
GET IT
Times cited: 207 -
Sexual health needs and educational intervention preferences for women with cancer.
Breast cancer research and treatment.
2017
Academic Article
GET IT
Times cited: 99 -
Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors.
Journal of cancer survivorship : research and practice.
2016
Academic Article
GET IT
Times cited: 54 -
Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia.
Breast cancer research and treatment.
2016
Academic Article
GET IT
Times cited: 18 -
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2016
Academic Article
GET IT
Times cited: 148 -
Cancer and Fertility Program Improves Patient Satisfaction With Information Received.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2016
Academic Article
GET IT
Times cited: 70 -
How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer.
Current opinion in supportive and palliative care.
2016
Information Resource
GET IT
Times cited: 95 -
Communication About Sexuality in Advanced Illness Aligns With a Palliative Care Approach to Patient-Centered Care.
Current oncology reports.
2016
Information Resource
GET IT
Times cited: 16 -
Fertility Preservation for the Young Breast Cancer Patient.
Annals of surgical oncology.
2016
Academic Article
GET IT
Times cited: 32 -
A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer.
Clinical breast cancer.
2015
Academic Article
GET IT
Times cited: 1 -
The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysis.
The British journal of dermatology.
2015
Letter
GET IT
Times cited: 34 -
Baseline characteristics and concerns of female cancer patients/survivors seeking treatment at a Female Sexual Medicine Program.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
2015
Academic Article
GET IT
Times cited: 24 -
Endocrine therapy and its effect on sexual function.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
2015
Review
GET IT
Times cited: 2 -
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2014
Academic Article
GET IT
Times cited: 71 - Observation of an excited Bc(±) meson state with the ATLAS detector. Physical review letters. 2014 Academic Article GET IT
- Search for scalar diphoton resonances in the mass range 65-600 GeV with the ATLAS detector in pp collision data at √s=8 TeV. Physical review letters. 2014 Academic Article GET IT
- Measurements of four-lepton production at the Z resonance in pp collisions at sqrt[s] = 7 and 8 TeV with ATLAS. Physical review letters. 2014 Academic Article GET IT
-
Comparative patient-centered outcomes (health state and adverse sexual symptoms) between adjuvant brachytherapy versus no adjuvant brachytherapy in early stage endometrial cancer.
Annals of surgical oncology.
2014
Academic Article
GET IT
Times cited: 9 -
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer.
Clinical breast cancer.
2013
Academic Article
GET IT
Times cited: 69 -
A national network to advance the field of cancer and female sexuality.
The journal of sexual medicine.
2013
Academic Article
GET IT
Times cited: 19 -
Quality of life and symptoms in male breast cancer survivors.
Breast (Edinburgh, Scotland).
2013
Academic Article
GET IT
Times cited: 16 -
Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.
Radiology.
2012
Academic Article
GET IT
Times cited: 56 -
Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy.
International journal of radiation oncology, biology, physics.
2012
Academic Article
GET IT
Times cited: 42 -
Bevacizumab for advanced breast cancer.
Women's health (London, England).
2010
Review
GET IT
Times cited: 4 -
Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes.
Journal of the National Cancer Institute.
2009
Academic Article
GET IT
Times cited: 491 -
Electronic patient-reported outcomes for collecting sensitive information from patients.
The journal of supportive oncology.
2009
Article
GET IT
Times cited: 16 -
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.
Breast cancer research and treatment.
2006
Academic Article
GET IT
Times cited: 74 -
FRAP DNA-dependent protein kinase mediates a late signal transduced from ultraviolet-induced DNA damage.
The Journal of investigative dermatology.
2000
Academic Article
GET IT
Times cited: 25